RPRX

Q: What is the price of Royalty Pharma (RPRX) today?

The price of Royalty Pharma (RPRX) today is $ 47.47, with return of 45.52% compared to the last year. The price of Royalty Pharma (RPRX) started the year trading around $ 38.64 and today it is at $ 47.47. Follow the real-time price chart, the historical price of Royalty Pharma (RPRX) and international markets.

Q: When does Royalty Pharma (RPRX) pay dividends?

Royalty Pharma (RPRX) did not distribute dividends in the last year.

Q: Is Royalty Pharma (RPRX) worth it?

Currently, Royalty Pharma (RPRX) is priced at $ 47.47, with a P/E of 25.66%, representing a deviation of 10,469% from its historical average P/E. In the last year, the stock showed a variation of 45.52 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 1.90%. The total shareholder return was 45.52%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Royalty Pharma (RPRX) stock?

Investing in stocks of Royalty Pharma (RPRX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Royalty Pharma (RPRX) yield today?

The yield of Royalty Pharma (RPRX) was 13.89% in the last month, 45.52% in the last year and 26.62% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.88 in dividends, with a Dividend Yield of 1.90%.If you wanted to buy 100 stocks of Royalty Pharma (RPRX) today, the total investment would be $ 4,747.00, based on the current price of $ 47.47.If past performance were to repeat, the return on your investment would be:In 1 year: $ 6,907.83In 5 years: $ 6,010.65In 10 years: $ 4,747.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Royalty Pharma PLC

Price

$ 47.47

return (12m)

45.52%

p/e

25.66

p/b

2.04

DIVIDEND YIELD

1.90%

price RPRX

RPRX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of RPRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

13.89%

3 months

21.47%

1 year

45.52%

2 years

68.62%

5 years

26.62%

10 years

0.00%

Fundamentals RPRX

review the fundamentals of Royalty Pharma shares

P/E

25.66

Sector: -141.01 Industry: 10.06

P/S (Price-to-Sales)

8.32

Sector: 1.12 Industry: 1.38

P/B

2.04

Sector: -6.77 Industry: 1.43

DIVIDEND YIELD (DY)

1.90%

Sector: 0.40% Industry: 0.52%

ROA

3.93%

Sector: -1,447.11% Industry: 2.31%

ROE

7.93%

Sector: -3,191.43% Industry: 11.19%

ROIC

8.53%

Sector: -7.90% Industry: -3.18%

NET MARGIN

32.41%

Sector: -0.37% Industry: 8.29%

GROSS MARGIN

100.00%

Sector: -0.52% Industry: 26.45%

OPERATING MARGIN

65.54%

Sector: -5.71% Industry: 5.96%

EV/EBITDA

12.11

Sector: -123.73 Industry: 2.79

EV/EBIT

12.12

Sector: -130.69 Industry: -2.15

PRICE-TO-ASSETS

1.01

Sector: 0.12 Industry: 0.41

BVPS

22.70

Sector: -1,452.28 Industry: 22.12

EPS

1.80

Sector: -6,098.44 Industry: 3.04

EQUITY-TO-ASSETS RATIO

0.50

Sector: 0.00 Industry: 0.22

LIABILITIES / ASSETS

0.50

Sector: 0.30 Industry: 0.66

CAGR REVENUE 5 YEARS

0.76%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

4.46%

Sector: - Industry: -

FAIR VALUE OF Royalty Pharma ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 47.47

Fair Value

$ 0.00

Upside Return potential.

-36.13%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals RPRX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/b	ROE	dy	market cap	net margin
JPM	14.40	2.27	15.74%	1.93%	$ 821.32 B	31.27%
NU	28.66	6.87	23.96%	0.00%	$ 72.49 B	26.35%
MA	31.00	59.89	193.24%	0.61%	$ 463.94 B	45.65%
BAC	11.98	1.21	10.10%	2.17%	$ 367.00 B	27.77%
BRK-B	16.14	1.55	9.63%	0.00%	$ 1.09 T	16.84%
HSBC	17.77	1.58	8.90%	3.63%	$ 314.46 B	25.26%
BRK-A	11.22	1.08	9.63%	0.00%	$ 757.00 B	16.84%
C	13.66	0.91	6.69%	2.14%	$ 195.37 B	16.79%
RY	16.03	2.34	14.62%	2.61%	$ 233.11 B	30.61%
BLK	29.68	2.66	8.98%	1.96%	$ 164.80 B	22.93%
PYPL	8.23	2.13	25.83%	0.30%	$ 43.07 B	15.78%
ING	11.57	1.41	12.16%	4.76%	$ 83.91 B	27.55%
PAGS	7.95	1.11	14.03%	4.72%	$ 3.10 B	11.33%
AXP	19.59	6.34	32.36%	1.06%	$ 212.21 B	15.00%
WFC	11.89	1.39	11.66%	2.15%	$ 253.64 B	25.49%
BBVA	11.60	1.93	16.62%	3.53%	$ 139.50 B	27.47%
XP	11.96	2.59	21.68%	0.84%	$ 11.20 B	64.74%
LYG	12.87	1.25	9.68%	3.12%	$ 79.82 B	23.92%
MS	15.45	2.35	15.18%	2.36%	$ 260.42 B	25.56%
BCS	8.81	0.80	9.13%	1.79%	$ 84.25 B	24.59%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

RPRX Historical Dividends

current DY: 1.90%

5-year average DY: 2.47%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	02/20/2026	03/10/2026	0,23500000
Dividend	11/14/2025	12/10/2025	0,22000000
Dividend	08/15/2025	09/10/2025	0,22000000
Dividend	05/16/2025	06/10/2025	0,22000000
Dividend	02/21/2025	03/10/2025	0,22000000
Dividend	11/15/2024	12/10/2024	0,21000000
Dividend	08/16/2024	09/13/2024	0,21000000
Dividend	05/17/2024	06/14/2024	0,21000000
Dividend	02/16/2024	03/15/2024	0,21000000
Dividend	11/17/2023	12/15/2023	0,20000000
Dividend	08/18/2023	09/15/2023	0,20000000
Dividend	05/19/2023	06/15/2023	0,20000000
Dividend	02/16/2023	03/15/2023	0,20000000
Dividend	11/18/2022	12/15/2022	0,19000000
Dividend	08/19/2022	09/15/2022	0,19000000
Dividend	05/20/2022	06/15/2022	0,19000000
Dividend	02/18/2022	03/15/2022	0,19000000
Dividend	11/19/2021	12/15/2021	0,17000000
Dividend	08/20/2021	09/15/2021	0,17000000
Dividend	05/20/2021	06/15/2021	0,17000000
Dividend	02/19/2021	03/15/2021	0,17000000
Dividend	11/20/2020	12/15/2020	0,15000000
Dividend	09/15/2020	09/30/2020	0,15000000

ABOUT THE COMPANY Royalty Pharma

Royalty Pharma PLC

Average user rating I10

4.0 (2 people)

United States

6 years

Founded: 2020

2020

Time since IPO - 6 years

-

Employees

The Company Royalty Pharma PLC (United States), is listed on Nasdaq with a market value of $ 19.78 Billions, having an equity of $ 9.71 Billions.

The Company is listedthe in the sector of Financial and categorized in industry of Auxiliary Activities of Financial Services.

In the last 12 months the Company had a revenue of $ 2.38 Billions, which generated a profit in the amount of $ 770.74 Millions.

As for its main indicators, the Company has a P/E ratio of 25.66, a P/BV ratio of 2.04 and in the last 12 months the dividend yield of RPRX was at 1.90%.

The Company is traded internationally through the ticker RPRX.

Market cap

$ 19.78 Billions

Net worth

$ 9.71 Billions

US$ 9,714,940,000.00

Assets

$ 19.62 Billions

US$ 19,620,780,000.00

Total Shares Outstanding

428.00 Millions

428,000,000

Average Daily Trading Volume

$ 3.68 Millions

US$ 3,680,026.02

Sector

Financial

Industry

Auxiliary Activities of Financial Services

RPRX

RPRX revenue and profits

Financial Results RPRX

DRAG THE FRAME TO SEE MORE DATA

RPRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BRK-A - Berkshire Hathaway

$ 720,000.00 --5,92% (12M)

P/E

11.22

0.00%

ROE

9.63%

P/B

1.08

BRK-B - Berkshire Hathaway

$ 480.17 --5,86% (12M)

P/E

16.14

0.00%

ROE

9.63%

P/B

1.55

JPM - JPMorgan

$ 297.56 16,51% (12M)

P/E

14.40

1.93%

ROE

15.74%

P/B

2.27

SNEX - StoneX Group

$ 130.65 59,04% (12M)

P/E

18.07

0.00%

ROE

14.27%

P/B

2.58

BAC - Bank of America

$ 49.81 12,49% (12M)

P/E

11.98

2.17%

ROE

10.10%

P/B

1.21

MET - MetLife

$ 73.24 --11,43% (12M)

P/E

13.93

3.14%

ROE

11.68%

P/B

1.63

PGR - Progressive

$ 213.41 --20,29% (12M)

P/E

11.07

6.51%

ROE

37.29%

P/B

4.13

WFC - Wells Fargo

$ 82.58 9,53% (12M)

P/E

11.89

2.15%

ROE

11.66%

P/B

1.39